Agilent and Monash University Malaysia Launch MUMPMP–Agilent BioDiscovery Hub to Boost Proteomics and Metabolomics Research

Agilent Technologies has expanded its long-standing partnership with Monash University Malaysia (MUM) to establish the MUM Proteomics & Metabolomics Platform (MUMPMP)–Agilent BioDiscovery Hub, a dedicated centre for advanced life‑science research serving Malaysia and the wider Asia‑Pacific region.

Purpose and Scope

The hub is designed to accelerate biotechnology research and innovation by providing access to state‑of‑the‑art instrumentation, hands‑on training and collaborative research programmes. The renewed memorandum of understanding (MOU), signed to mark 15 years of collaboration between the organisations, highlights Agilent’s continued investment in research and development across fast‑growing Asian markets.

Equipment and Capabilities

Under the agreement, Agilent will supply advanced analytical systems to the BioDiscovery Hub, including the Revident Quadrupole Time‑of‑Flight (Q‑TOF) LC/MS systems, the 1290 Infinity III high‑performance liquid chromatography series, and the 5977C gas chromatograph/mass selective detector (GC/MSD). These instruments will support research programmes, application development, workshops and scientific training for students and researchers.

Research Impact

The partnership aims to accelerate R&D in both small‑ and large‑molecule analysis, strengthening activities in pharmaceutical development, biomedical research, molecular biology and lipidomics. By combining Agilent’s technologies with Monash’s multidisciplinary research ecosystem, the hub is expected to drive new applications, improve analytical throughput and strengthen regional research capacity.

Dr Syafiq Asnawi, Director of the MUM Proteomics & Metabolomics Platform and Senior Lecturer in Biomedical Science, said:

“The MUMPMP–Agilent BioDiscovery Hub strengthens Monash’s position as a regional leader in proteomics, metabolomics and biotechnology innovation. By combining Agilent’s state‑of‑the‑art technologies with Monash’s research excellence and multidisciplinary ecosystem, we are empowering our scientists and partners to drive impactful solutions for Malaysia and the Asia‑Pacific region.”

Bharat Bhardwaj, Vice‑President of Sales for Agilent Technologies Asia Pacific, added:

“At Agilent, we support Monash University in enhancing biological research through proteomics, metabolomics and lipidomics. The BioDiscovery Hub will drive scientific progress, talent development and create long‑term value for customers and partners.”

Agilent has operated in Malaysia for more than two decades and continues to support the country’s scientific development through partnerships with academic institutions and workforce training initiatives. The BioDiscovery Hub is expected to expand research training opportunities and foster industry‑academic collaborations in the region.

Originally published by Pharmaceutical Technology, a GlobalData‑owned brand. This article is provided for general informational purposes and is not intended as professional advice.